Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(6-Chloro-pyridine-3-sulfonyl)-4-methyl-piperazine → 3-{5-[(4-Methylpiperazin-1-yl)sulfonyl]pyridin-2-yl}-5-(1,3-oxazol-5-yl)-1H-indol-2-ol
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(6-Chloro-pyridine-3-sulfonyl)-4-methyl-piperazine | HCID 822457 | — |
| 반응물 | HCID 11008941 | HCID 11008941 | — |
| 생성물 | 3-{5-[(4-Methylpiperazin-1-yl)sulfonyl]pyridin-2-yl}-5-(1,3-oxazol-5-yl)-1H-indol-2-ol | HCID 136342141 | 1% |
반응 단계
The title compound was prepared as described for Example 101 using 1-[(6-chloropyridin-3-yl)sulfonyl]-4-methylpiperazine (described in: Thunus L., Annales Pharmaceutiques Francaises 1977, 35, 197-203) and 5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one. The crude product was purified on a silica gel column using chloroform/methanol/conc NH3(aq), (100:10:1), as the eluent followed by trituration in ethyl acetate. Yield: 1% of the title compound: MS (ES) m/z 441 (M++1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07399780B2 |
| 출처 데이터셋 | uspto-grants-2008_07 |
| ORD ID | ord-c793575710764953919a22c768d23887 |
| 출처 메모 | uspto-grants-2008_07 |